1. < Hematology

Chimeric antigen receptor T cell therapy (CAR-T cell therapy): How it works and what is next

Sep 25, 2018 | Mayo Clinic Hematology Staff | @mayoclinichematologystaff

Dr. Yi Lin, chair of the Cellular Therapeutics Cross-Disciplinary Group at the Mayo Clinic Cancer Center, explains how chimeric antigen receptor T cell therapy (CAR-T cell therapy) works and where the research is headed next.

Learn more about the basics of the breakthrough cancer treatment and where the research is heading next.

Connect with real members discussing their diagnoses in the Blood Cancers & Disorders group, as well as the CAR-T Cell Therapy group.

Lin, Yi M.D.

Interested in more newsfeed posts like this? Go to the Hematology blog.

Please sign in or register to post a reply.